---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-012404"
form_type: "8-K"
ticker: "CURX"
cik: "0002025942"
company_name: "Curanex Pharmaceuticals Inc"
filed_at: "2025-08-27T23:59:59+00:00"
generated_at: "2026-05-17T09:49:01.463527+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Curanex Pharmaceuticals closes IPO of 3.75M shares at $4.00, raising $15M gross

## Summary
- Gross proceeds of $15M from IPO of 3,750,000 shares at $4.00 per share on firm commitment basis.
- Net proceeds approximately $12.1M after underwriting discounts and estimated offering expenses.
- Common stock began trading on Nasdaq Capital Market on Aug 26, 2025 under ticker CURX.
- Underwriters granted 45-day option to purchase up to 562,500 additional shares at $4.00 per share.
- Lead underwriter Dominari Securities LLC; co-underwriters Pacific Century Securities LLC and Revere Securities LLC.

## SEC filing metadata
- accession: 0001493152-25-012404
- form_type: 8-K
- ticker: CURX
- cik: 0002025942
- company_name: Curanex Pharmaceuticals Inc
- filed_at: 2025-08-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2025942/000149315225012404/0001493152-25-012404-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2025942/000149315225012404/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-012404
- JSON: https://secwatch.observer/filing/0001493152-25-012404.json
- Plain text: https://secwatch.observer/filing/0001493152-25-012404.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.